Keyphrases
Extracellular Vesicles
76%
Hepatic Stellate Cell Activation
49%
Hepatic Stellate Cells
42%
Kupffer Cells
37%
Cell-to-cell
25%
Mutual Activation
25%
Metabolic-associated Fatty Liver Disease (MAFLD)
21%
Intercellular Communication
17%
Liver Fibrosis
17%
Liver ECM
15%
Conditioned Medium
13%
Inflammatory Phenotype
13%
Liver
12%
Akt-mTOR Signaling
12%
Cell Senescence
12%
Diseases Therapeutic
12%
Disease Mechanisms
12%
ITRAQ Analysis
12%
Biochanin A
12%
Steatotic Hepatocytes
12%
Disease Diagnosis
12%
Prognostic Implications
12%
Therapeutic Implications
12%
Liver Sinusoidal Endothelial Cells
12%
Arctigenin
12%
Lipid Homeostasis
12%
Endoplasmic Reticulum-associated Degradation
12%
Endoplasmic Reticulum Stress (ER stress)
12%
Liver Cells
12%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
12%
Soluble Factors
12%
Scar
7%
Hepatocytes
6%
Cell-derived
6%
Fibrosis
6%
Toll-like
6%
Fatty Liver Disease
5%
Biochemistry, Genetics and Molecular Biology
Hepatic Stellate Cell
100%
Kupffer Cell
62%
Proteomics
28%
Cell Activation
27%
Cell Dedifferentiation
20%
Wistar Rat
15%
Hepatocyte
12%
Molecular Weight
12%
Primary Culture
12%
Pig
12%
Rigidity
12%
Tissue Culture
12%
Catalase
12%
Scanning Electron Microscopy
12%
Stem Cell
12%
TLR4
12%
Real-Time Polymerase Chain Reaction
12%
Gene Expression
11%
Protein Expression
11%
Immunofluorescence
11%
Target Cell
9%
Type I Collagen
9%
Bromodeoxyuridine
8%
Mediator
6%
Homeostasis
6%
Western Blotting
6%
Liver Function
6%
Glycosaminoglycan
6%
Macromolecule
6%
Protein Content
6%
Cell Death
6%
Glycosaminoglycan
6%
Propidium Iodide
6%
Cell Function
6%
Fluorescein
6%
Protein Function
6%
CD31
6%
Cell Viability
6%
Coculture
5%
Cell Communication
5%
Medicine and Dentistry
Endothelial Cell
65%
Hepatic Stellate Cell
50%
In Vitro
26%
Kupffer Cell
25%
Cell Communication
16%
Mediator
15%
Diagnosis
14%
Catalase
12%
Non-Alcoholic Fatty Liver Disease
12%
Extracellular Matrix
12%
Liver Cell
12%
Scar Formation
12%
Metabolic Dysfunction-Associated Steatotic Liver Disease
6%
Fibrosis
6%
Homeostasis
6%
Hexane
6%
Fatty Liver
6%
Liver Disease
5%
Liver Cirrhosis
5%
Target Cell
5%
BrdU Assay
5%
